Medications associated with Multiple Sclerosis
Ingredients whose current FDA labeling lists an association with multiple sclerosis, extracted from manufacturer submissions via NIH DailyMed.
Label-linked ingredients
Alemtuzumab
LEMTRADA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include relapsing-re...
Baclofen
Baclofen injection (intrathecal) is indicated for use in the management of severe spasticity. Patients should ...
Cladribine
Cladribine tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include r...
Dalfampridine
Dalfampridine extended-release tablets are indicated as a treatment to improve walking in adult patients with ...
Fingolimod
Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include ...
Glatiramer
Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to ...
Hydroxocobalamin
Pernicious anemia, both uncomplicated and accompanied by nervous system involvement. Dietary deficiency of Vit...
Interferon Beta-1A
AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically iso...
Interferon Beta-1B
BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically ...
Mitoxantrone
Mitoxantrone injection, USP (concentrate) is indicated for reducing neurologic disability and/or the frequency...
Monomethyl Fumarate
Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple scle...
Ocrelizumab
OCREVUS is indicated for the treatment of: Relapsing forms of multiple sclerosis (MS), to include clinically i...
Ofatumumab
KESIMPTA is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically i...
Ozanimod
ZEPOSIA is indicated for the treatment of: relapsing forms of multiple sclerosis (MS), to include clinically i...
Peginterferon Beta-1A
PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically i...
Ponesimod
PONVORY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically is...
Siponimod
MAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically is...
Teriflunomide
Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to inclu...
Ublituximab
BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically is...
Lab tests that investigate multiple sclerosis
Autoimmune Disorder Panel
Order Autoimmune Disorder Panel.com online through our partner and visit a local lab near you....
CBC with Differential
Measures red blood cells, white blood cells, and platelets to help evaluate overall health and detect disorder...
Vitamin D 25-Dihydroxy Calcitriol Test
This blood test is used to determine Vitamin D 25-dihydroxy (calcitriol) deficiencies. It is used in the diagn...
Vitamin D Blood Test
This blood test measures the Vitamin D 25-Hydroxy (Calcidiol) levels. Vitamin D is absorbed through sunlight, ...
Vitamin D, 25-Hydroxy
Measures vitamin D levels to detect deficiency or insufficiency....
Frequently Asked Questions
What medications are used for multiple sclerosis?
The medications listed above are associated with multiple sclerosis in current FDA-approved labeling as reported by manufacturers through NIH DailyMed. Only a qualified prescriber can determine appropriate treatment.
Do these medications cure multiple sclerosis?
This site does not provide treatment advice. The list reflects labeled associations, not recommendations. Discuss options, risks, and benefits with your healthcare provider.
Medical disclaimer: Educational content only. Not medical advice or a treatment recommendation.